Navigation Links
Weight-loss proves effective cure for sleep apnea
Date:12/4/2009

researchers also noted that the effect of the weight loss programme was greatest in patients with severe sleep apnoea.

To achieve significant weight loss, the treatment group were put on a very low calorie diet (VLCD), which gave them an initial energy input of 554 kcal per day for seven weeks followed by a fortnight's successive increase up to 1,500 kcal per day at week nine. The control group maintained their normal dietary habits during the nine week study period, but was afterwards offered a VLCD programme.

After the VLCD period, the participants were also invited to take part in a year's behavioural change programme to help them maintain their weight loss.

"We often use VLCD in the form of a low calorie powder as part of the treatment of obese patients with a serious comorbidity, such as sleep apnoea," says Ms Johansson. "The powder is mixed with water and replaces every meal of the day, which gives a rapid loss of weight. It's also a good way of boosting the patients' motivation."

The researchers stress that the VLCD diet is not a general solution to weight problems, but something mainly to be used in the first phase of a long-term treatment programme. To keep the weight off, patients need to work hard to improve their dietary and exercise habits, usually with the aid of a long-term behaviour modification programme. Drugs can also be used in the post-weight loss phase to further improve weight loss maintenance.

The current study was part funded by Cambridge Manufacturing Company Limited, which markets the Cambridge Diet, the low-calorie powder used in the study. The company had no influence on the study, the analyses or the collation of the results. Examples of similar VLCD products marketed by other companies are Nutrilett, Naturdiet and Allevo. The researchers who conducted the study work at the Obesity Unit, Karolinska University Hospital, Huddinge, and the Clinical Epidemiology Unit, Karolinska Institutet.


'/>"/>
Contact: Katarina Sternudd
katarina.sternudd@ki.se
46-852-483-895
Karolinska Institutet
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. SENSA(R) WEIGHT-LOSS PROGRAM: The Accidental Discovery Thats Transforming The Way People Lose Weight Breaks the Top 500 at Amazon.com in Less Than Two Weeks of Publication
2. New Product Launch - SAFFRENE Delivers Impressive Mood Elevation and Weight-loss Benefits
3. Delaying Weight-Loss Surgery May Leave Teens at Risk
4. Weight-Loss Surgery Breaks Families Obesity Cycle
5. FDA Investigating Weight-Loss Drug Over Reports of Liver Damage
6. Study Finds Weight-Loss Surgery Safer Than Thought
7. Weight-Loss Enzyme Identified
8. Jillian Michaels, Americas Toughest Trainer, Announces New Line of Weight-Loss Supplements
9. Obese Poor Shut Out From Weight-Loss Surgeries
10. Weight-Loss Surgery Safe, Effective Type 2 Diabetes Treatment
11. Common Weight-Loss Surgery May Double Risk of Kidney Stones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 Decene is an alkene ... of ten carbon atoms with one double bond. ... 1-decenes. It can be used as a co-monomer ... produce epoxides, amines, oxo alcohols, synthetic lubricants, synthetic ... buyers will receive 10% customization on this report. ...
(Date:7/30/2014)... Naomi Fried, PhD, and Alexis Gilroy, ... of the American Telemedicine Association (ATA). The ... a mission to promote professional, ethical and equitable ... technology. , “Both Naomi Fried and Alexis Gilroy, ... and are well known experts in their respective ...
(Date:7/30/2014)... (HealthDay News) -- Clues to whether a person is at ... a new study suggests. Chemical changes to a gene ... spur suicidal thoughts and behaviors, the study,s authors explained. Spotting ... to a patient,s risk for suicide, they said. "Suicide ... been stymied in our prevention efforts because we have no ...
(Date:7/30/2014)... The global digital pathology market was valued at ... grow at a CAGR of 11.8%, to reach an estimated ... is growing and is expected to continue to rise in ... image analysis software enable pathologists to be efficient and this ... the North American market was valued at $128.9 million and ...
(Date:7/30/2014)... release is available in French . ... by Claude Gronfier (Inserm Unit 846: Stem Cell and ... study under real conditions on the body clocks of ... researchers have shown that a particular kind of artificial ... are correctly synchronised despite the absence of sunlight. The ...
Breaking Medicine News(10 mins):Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Europe 1-decene Market is Expected to Reach 251.7 thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:American Telemedicine Association Welcomes Two New Members to the Board of Directors 2Health News:Could a Blood Test Predict Suicide Risk? 2Health News:Could a Blood Test Predict Suicide Risk? 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 4Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 5Health News:Dimly lit working environments: Correcting your body clock is possible! 2Health News:Dimly lit working environments: Correcting your body clock is possible! 3Health News:Dimly lit working environments: Correcting your body clock is possible! 4
... Minister Frank Nweke has said in a statement that a ... states//, and one among them is Nigeria’s southern most state. ... the central state of Benue and Port Harcourt in Rivers ... virus. According to Frank, "The culling of infected birds and ...
... treatment of erectile dysfunction or impotence can now be ... disease//. Pfizer, a leading pharmaceutical company, is marketing the ... ,The drug approved for use in last ... the same active ingredients as the pill, Viagra. The ...
... Unilever has announced a partnership with the World Dental ... Middle East and Turkey.// Both organizations will assist National ... spread awareness about the importance of oral health. ... Learn. Laugh. The programs include school education programmes and ...
... Researchers at the University of Illinois at Urbana-Champaign ... nanoparticles to produce new drug and agricultural materials ... materials science and engineering, chemistry and physics said ... hollow, deformable and biofunctional capsules could be used ...
... governor of South Dakota signed a law banning abortions, which ... and also which may trigger national debate. // ... Supreme Court decision, known as Roe vs. Wade, that made ... abortion. ,Governor Mike Rounds, a member of President ...
... back slowly after its steep fall from grace, following the ... bies and on the house access to chicken delicacies have ... onto people’s plates. ,The farm-gate prices had recorded ... 1.20 while the chicken prices had hit rock bottom at ...
Cached Medicine News:Health News:Medical Boon in the Form of a Biofriendly Capsule 2
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron Pharmaceuticals, ... SAN and NYSE: SNY ) today announced ... in people with hypercholesterolemia met their primary efficacy endpoint ... lipoprotein cholesterol (LDL-C) at 24 weeks compared to placebo ... targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... and NEW YORK , July ... a developer of new products for oncology supportive care, ... ® , has been featured in an article on ... Symptoms in Head and Neck Cancers."  Dr. Steve ... insight on the growing demand seen in the oncology ...
(Date:7/30/2014)... July 30, 2014   Bluegrass Vascular Technologies ... innovating lifesaving devices and methods for vascular access, ... Series A financing, which was led by ... deal will allow Bluegrass Vascular to obtain CE ... enhance manufacturing capabilities, and proceed with US regulatory ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds 2
... July 27, 2011 Pharmaceutics International, Inc. (Pii), a ... it has added hot melt extrusion (HME) to its ... has purchased a 16mm and an 18mm Leistritz twin ... feasibility studies, using just a few grams of active ...
... Pharmaceuticals, Inc., announced today that the company has ... Angel Investors. The company is using the capital ... orphan receptor (ROR) modulators targeting TH17 T-lymphocytes for ... arthritis, multiple sclerosis, psoriasis and COPD. ...
Cached Medicine Technology:Pharmaceutics International, Inc. (Pii) Expands Drug Formulation and Manufacturing Capabilities with Hot Melt Extrusion Technology 2Visionary Pharmaceuticals, Inc., Announces Initial Seed Round Investments and the Launch of TH17 Autoimmune Disease Research Activities 2
... Guide 2005 includes over 1,000 commonly used ... their selection and administration. Organized alphabetically by ... key data featuring common uses and side ... patient education information. A list of the ...
... Drugs is a dynamic new mobile ... easy to check on the compatibility ... selected drugs, clear compatibility and stability ... quickly take clinical action based on ...
Providing patients and their advocates with a variety of information services and educational materials on clinical research....
... DrDrugs®: Drug Guide ... with over 760 Integrated ... most comprehensive, up-to-date and ... built in drug dosing ...
Medicine Products: